Dr Luke Butler presents first findings of White Paper on diagnostics procurements during Covid at BIVDA

On Wednesday 12 October, Luke Butler presented provisional findings from his White Paper titled “Diagnostics Procurement in the Covid-19 Pandemic, Lessons Learned and Recommendations for the Future” at the British In Vitro Diagnostic Association (BIVDA) Mid-Year General Meeting.

The White Paper is the product of an industry grant funded by BIVDA and assesses the procurement and approval of lateral flow and PCR test kits. BIVDA is also partnering with the University of Nottingham on the ESRC Impact Leaders Programme. This research is topical and timely in view of the recent judgment concerning the Good Law Project challenge to diagnostics contracts awarded by the Department of Health and Social Care to Abingdon Health Plc [2022] EWHC 2468 (TCC). BIVDA is referenced in the judgment.